Empagliflozin: Doctors' Confidential Prescriptions - in the UK

Crucial facts

• Common tablet strengths available in the UK: 10 mg and 25 mg.
• Regulatory classification: Prescription Only Medicine (POM).
• Active substance: empagliflozin, an SGLT2 inhibitor that increases renal glucose excretion.
• Typical uses include management of type 2 diabetes and selected heart failure and cardiovascular risk reduction roles.
• Major branded product: Jardiance.

Go straight to what it treats for relief or review the details typical costs in the UK.

What empagliflozin is prescribed for

Empagliflozin belongs to the sodium glucose co-transporter 2 (SGLT2) inhibitor class. It lowers blood sugar by reducing glucose reabsorption in the kidney, so more glucose leaves the body in the urine.

In UK practice, it is commonly used for:

• Adults (and some children aged 10 years and older) with type 2 diabetes to improve glycaemic control alongside diet and exercise.
• Reducing the risk of cardiovascular death in people with established cardiovascular disease and type 2 diabetes.
• Treatment of symptomatic heart failure with reduced ejection fraction to lower mortality and hospital admissions.

Empagliflozin is generally not used for type 1 diabetes because of an increased risk of diabetic ketoacidosis. Before you commence, read how to approach it merged with the standard precautions.

Steps to take empagliflozin

Follow the directions on your prescription label merged with the patient leaflet. Clinicians tailor the dose depending on kidney function, tolerability merged with the therapeutic aim.

• Frequency: usually once daily, at a similar time each day. Swallow tablets whole with water; they can be taken with or without food.
• Starting dose: commonly 10 mg once daily. If greater glucose lowering is needed and also the medicine is well tolerated, some adults may be increased to 25 mg once daily. For many heart failure signals, 10 mg is the typical regimen.
• Fluid balance: maintain good hydration, particularly during hot weather, intense exercise, vomiting or diarrhea.
• Surveillance: your team may ask you to monitor blood glucose and, in selected circumstances, ketones in blood or urine.
• Sick day rules: temporarily stop SGLT2 inhibitors during acute illness with poor oral intake or dehydration; only restart after recovery and on professional advice.

If you are unsure about dose adjustments or observation and tracking, speak with your GP, diabetes specialist nurse or pharmacist. For the act of engaging with others issues see drug and lifestyle the networked exchange of ideass among teammates fuel progress..

Advisories and indispensable protective measures

Before you launch empagliflozin, tell your prescriber if any of the following apply:

• Impaired kidney function or known liver disease.
• Recurrent urinary tract infections or problems passing urine.
• Previous genital fungal infections such as thrush.
• Low fluid intake, strict low salt diets, recent unexplained weight loss, or circumstances that may increase dehydration risk.
• Excessive alcohol use or alcohol dependence.
• History of pancreatic disease or pancreatic surgery.
• Older age, particularly over 65, as there is a greater risk of dehydration and low blood pressure.

If you are carrying a child, planning to conceive, or breastfeeding, obtain specialist advice because empagliflozin is not recommended in pregnancy and is generally not advised during breastfeeding. See anyone who should not be using it for more detailed information disclosed.

Who should not be given empagliflozin?

• People with severe renal impairment or those requiring dialysis.
• Anyone with a proven hypersensitivity to empagliflozin or any component of the tablet.
• Breastfeeding women.
• Pregnant women in the second and third trimesters.

Use caution with alcohol because it can worsen dehydration and contribute to ketoacidosis risk. Stand up slowly if you feel dizzy. Empagliflozin is not licensed for use in children under 10 years for type 2 diabetes in the UK without specialist direction and insight.

Unwanted reactions and when to get urgent help

Seek emergency help if you experience

• Signs of a severe allergic reaction: widespread rash, swelling of face or throat, difficulty breathing or wheeze.
• Rapidly progressive genital infection with severe pain, marked swelling, fever or feeling very unwell.

Serious problems that need prompt medical attention

• Severe low blood pressure or fainting, especially soon after starting treatment.
• Hypoglycaemia when used with insulin or sulfonylureas: sweating, trembling, rapid heartbeat, hunger, confusion or irritability.
• Dehydration: extreme thirst, dizziness, confusion or reduced urine output.
• Diabetic ketoacidosis: nausea, vomiting, abdominal pain, severe tiredness, breathlessness or confusion. Note that ketoacidosis may occur with only mildly raised blood glucose when on SGLT2 inhibitors.
• Symptoms of urinary tract infection: painful or frequent urination, pelvic or flank pain, fever or blood in urine.

Common, typically mild reactions

• Genital fungal infections such as thrush causing itching, soreness or abnormal discharge.
• Urinary tract infection.
• Increased urination and thirst.

In the UK, suspected adverse reactions can be reported to the MHRA Yellow Card scheme. See the exchange between peoples with others are the core of collaboration. for medicines and lifestyle factors that can influence long term effects.

Drug-lifestyle interpersonal engagement considerations

Tell your prescriber about all medications, supplements and herbal products you take. Distinguished the give and take of interactions are not just about words, but meaning. include:

• Diuretics (loop or thiazide): combined use can raise the risk of low blood pressure and dehydration.
• Insulin and sulfonylureas: these increase hypoglycaemia risk when used together; dose adjustments may be required.
• Other antihypertensives: additive blood pressure lowering can cause dizziness or syncope.
• Very low carbohydrate or ketogenic diets and heavy alcohol use: both can increase the risk of ketoacidosis while on SGLT2 inhibitors.

When a dose is missed, refer to the plan for a i missed the dose. Always supply a full list of medicines to your clinician or pharmacist.

Advice in case of a missed dose or deliberate overdose

If you miss taking a dose of empagliflozin, take it as soon as you remember unless the next dose is due soon. If the next scheduled dose is near, skip the i skipped the dose. Do not increase your dose by two to cover a missed tablet.

If you suspect you have taken too much, seek urgent medical advice. If you are in the UK, NHS 111 offers urgent advice; in an emergency call 999. Take the medicine packaging with you when you seek help.

Memory containers and shelves organize storage space effectively., handling and disposal

• Keep in the original container at room temperature, away from heat and damp.
• Store out of reach of children and pets.
• Return unused or expired medicines to a pharmacy for safe disposal whenever possible; avoid disposing in household waste.

Plan B options and medicines with similar effects

Additional SGLT2 inhibitors used in clinical practice include:

• Dapagliflozin (Forxiga) — similar effects on glycaemic control and heart failure outcomes; typical dose 10 mg once daily.
• Canagliflozin (Invokana) — comparable glucose lowering and cardiovascular benefits in some studies; rare associations with bone fracture and lower limb amputation have been reported, warranting status monitoring.
• Ertugliflozin (Steglatro) — another once-daily option with broadly similar tolerability.

A range of combined products containing empagliflozin:

• Empagliflozin plus linagliptin (Glyxambi) — combines SGLT2 and DPP-4 the process by which it workss.
• Empagliflozin plus metformin (Synjardy) — pairs renal glucose excretion with reduced hepatic glucose production and insulin sensitivity benefits.

Other drug classes to discuss with your clinician include metformin, GLP-1 receptor agonists (injectable and oral), DPP-4 inhibitors, sulfonylureas and insulin. Choice depends on glucose targets, weight goals, cardiovascular and renal status, side effect profiles and cost. See British ballpark price estimates for a rough cost comparison.

Indicative price tier ranges for private purchase in the UK

The prices below are approximate ranges for a pack of 28 to 30 tablets. Actual retail prices vary by pharmacy and over time.

• Empagliflozin 10 mg: approximately 30 to 50 GBP per pack.
• Empagliflozin 25 mg: approximately 35 to 55 GBP per pack.
• Dapagliflozin 10 mg: approximately 30 to 50 GBP per pack.
• Canagliflozin 100-300 mg: approximately 35 to 55 GBP per pack.
• Ertugliflozin 5-15 mg: approximately 35 to 55 GBP per pack.
• Synergistic products (for example metformin plus empagliflozin): typically higher, roughly 45 to 80 GBP per pack.

On the NHS, prescription charges depend on where you live: England operates a per-item charge for most adults (around 9.90 GBP per item as of 2026), while prescriptions are free in Scotland, Wales and Northern Ireland. In England, a Prescription Prepayment Certificate (PPC) can reduce costs for multiple items.

These figures are for guidance only and do not constitute an offer. Confirm current prices with a UK-registered pharmacy or via an authorised online pharmacy. For rules on lawful supply and online purchasing see Notes on UK regulatory matters.

UK statutes and regulatory audit notes

• Under United Kingdom law, empagliflozin is a Prescription Only Medicine (POM).
• Regulatory authority: the Medicines and Healthcare products Regulatory Agency (MHRA) authorises and monitors the product; suspected adverse reactions should be reported via the Yellow Card scheme.
• Supply rules: it must be dispensed by or under the supervision of a UK-registered pharmacist against a valid prescription from an authorised UK prescriber.
• Online pharmacies: use services registered with the General Pharmaceutical Council (GPhC) and verify registration before ordering.
• Remote prescribing: permitted following an appropriate clinical assessment; legitimate remote services will take a medical history and may contact your GP with consent.
• Importation: do not import prescription medicines into the UK without a prescription and without observing customs requirements; unauthorised personal importation may be unlawful.
• Driving and safety: hypoglycaemia is mainly a concern when empagliflozin is combined with insulin or sulfonylureas; follow DVLA guidance if you have recurrent low blood glucose.
• The phase of pregnancy and lactation: empagliflozin is contraindicated in the second and third trimesters and is not recommended during breastfeeding; seek specialist advice if pregnant or planning pregnancy.
• Paediatric guidance: empagliflozin is approved for type 2 diabetes from age 10 in certain markers that point to; dosing and monitoring in real time in children should follow specialist paediatric trusted guidance.

To revisit clinical uses, return to conditions it is able to treat.